Intervention Review

Antiplatelet agents for preventing and treating pre-eclampsia

  1. Marian Knight2,
  2. Lelia Duley1,*,
  3. David J Henderson-Smart3,
  4. James F King4

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 18 APR 2007

Assessed as up-to-date: 20 FEB 2000

DOI: 10.1002/14651858.CD000492.pub2

How to Cite

Knight M, Duley L, Henderson-Smart DJ, King JF. Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD000492. DOI: 10.1002/14651858.CD000492.pub2.

Author Information

  1. 1

    University of Leeds, Centre for Epidemiology and Biostatistics, Bradford, West Yorkshire, UK

  2. 2

    Department of Public Health, Health Service Research Unit, Oxford, UK

  3. 3

    Queen Elizabeth II Research Institute, NSW Centre for Perinatal Health Services Research, Sydney, NSW, Australia

  4. 4

    Royal Women's Hospital, Department of Perinatal Medicine, Carlton, Victoria, Australia

*Lelia Duley, Centre for Epidemiology and Biostatistics, University of Leeds, Bradford Royal Infirmary, Bradford Institute of Health Research, Temple Bank House, Duckworth Lane, Bradford, West Yorkshire, BD9 6RJ, UK.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 18 APR 2007


Cited in:


This article has been cited by:

  1. 1
    Latha Ganti Stead, Seizures in Pregnancy/Eclampsia, Emergency Medicine Clinics of North America, 2011, 29, 1, 109


  2. 2
    Christian Pagnoux, Grossesse et vascularites, La Presse Médicale, 2008, 37, 11, 1657


  3. 3
    Alice Rumbold, Lelia Duley, Caroline A Crowther, Ross R Haslam, Antioxidants for preventing pre-eclampsia, The Cochrane Library,